Composition: Each vial contains 2.25 grams of a combination of Piperacillin (2 grams) and Tazobactam (0.25 grams), a broad-spectrum penicillin antibiotic and beta-lactamase inhibitor.
Indication: Used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.
Mechanism of Action: Piperacillin inhibits bacterial cell wall synthesis, leading to bacterial death, while Tazobactam blocks beta-lactamase enzymes, protecting Piperacillin from degradation.
Administration: Administered via intravenous infusion or slow injection, typically every 6 to 8 hours; dosage and duration depend on infection severity and patient condition.
Exports To: United States Of America | United Kingdom | Australia | Germany | Brazil
Find products similar to 2.25gm Piperacillin Tazobactam Injection
United States Of America | United Kingdom | Australia | Germany | Brazil
Bansal Multi Ventures, Established in 2023 Under the Leadership of CEO Yash Govind Agrawal, is a Trusted Exporter,Wholesaler,Distributor and Trader of High-quality Pharmaceutical Medicines. The Company Offers a Comprehensive Range of Products, Including Tablets, Capsules, Syrups, Creams, and Injections, Catering to Diverse Healthcare Needs. With a Strong Commitment to Quality, Reliability, and Timely Delivery, Bansal Multi Ventures Ensures That Healthcare Providers Receive Dependable Pharmaceutical Solutions. Guided by a Mission to Support Better Health Through Efficient Distribution and Exceptional Service, the Company Continues to Build Lasting Relationships Within the Medical and Healthcare Industry.
